Financing
Debt Repayments
Bristol-Myers Squibb Debt Repayments decreased by 100.0% to $0.00 in Q4 2024 compared to the prior quarter. Year-over-year, this metric declined by 100.0%, from $2.00B to $0.00. Over 3 years (FY 2021 to FY 2024), Debt Repayments shows a downward trend with a -21.9% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
StatementCash Flow Statement
SectionFinancing
CategoryRisk
SignalHigher is better
VolatilityModerate
First reportedQ4 2013
Last reportedQ4 2025
How to read this metric
Consistent repayment signals a strengthening balance sheet and a reduction in financial risk or leverage.
Detailed definition
The cash used to pay down the principal on outstanding loans, bonds, or commercial paper. This reduces the company's tot...
Peer comparison
Debt-heavy industries show high activity here; tech firms often use it to manage the maturity profile of their corporate bonds.
Metric ID:
cf_debt_repaymentHistorical Data
15 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.00B | $500.00M | $0.00 | $5.77B | $2.88B | $2.79B | $0.00 | $1.64B | $239.00M | $0.00 | $2.00B | $0.00 | $395.00M | $2.48B | $0.00 |
| QoQ Change | — | -50.0% | -100.0% | — | -50.1% | -3.2% | -100.0% | — | -85.4% | -100.0% | — | -100.0% | — | +527.3% | -100.0% |
| YoY Change | — | — | — | — | +187.7% | +457.0% | — | -71.6% | -91.7% | -100.0% | — | -100.0% | +65.3% | — | -100.0% |
Range$0.00 – $5.77B
CAGR-100.0%
Avg YoY Growth+30.8%
Median YoY Growth-81.6%
Debt Repayments at Other Companies
Frequently Asked Questions
- What is Bristol-Myers Squibb's debt repayments?
- Bristol-Myers Squibb (BMY) reported debt repayments of $0.00 in Q4 2024.
- How has Bristol-Myers Squibb's debt repayments changed year-over-year?
- Bristol-Myers Squibb's debt repayments decreased by 100.0% year-over-year, from $2.00B to $0.00.
- What is the long-term trend for Bristol-Myers Squibb's debt repayments?
- Over 3 years (2021 to 2024), Bristol-Myers Squibb's debt repayments has grown at a -21.9% compound annual growth rate (CAGR), from $6.02B to $2.87B.
- What does debt repayments mean?
- The amount of money a company spent to pay back its borrowed debt.